Year All20262025202420232022 February 24, 2026 Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results February 18, 2026 Ceribell to Participate in Upcoming March Investor Conferences February 10, 2026 Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 January 5, 2026 Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution December 30, 2025 Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference December 9, 2025 Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution November 24, 2025 Ceribell Receives FDA 510(k) Clearance for Use of Clarity® Algorithm for Neonates November 19, 2025 Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference November 6, 2025 Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 4, 2025 Ceribell Reports Third Quarter 2025 Financial Results
February 10, 2026 Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
January 5, 2026 Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
December 9, 2025 Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
November 6, 2025 Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
